- Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitorMerck’s once-daily pill is the first oral PCSK9 inhibitor to hit the market for high cholesterol, beating AstraZeneca in the race to develop more accessible treatment options.BioSpace · 11d ago↗ source
- STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and moreKalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvalsSTAT · 11d ago↗ source
- STAT+: FDA approves Merck’s oral PCSK9 drug, a firstKalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The ReadoutSTAT